Resources

Publish Date
Public Comments
C4IP Comments RE: U.K. IPO Consultation on SEPs
Infographics & Fact Sheets
Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Software and Technology

The Patent Eligibility Restoration Act of 2025 (PERA), sponsored by Sens. Thom Tillis (R-NC) and Chris Coons (D-DE), is bipartisan legislation that...

Infographics & Fact Sheets
Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Diagnostics and Life Sciences

The Patent Eligibility Restoration Act of 2025 (PERA), sponsored by Sens. Thom Tillis (R-NC) and Chris Coons (D-DE), is bipartisan legislation that...

Letters
C4IP Letter to House Judiciary Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet RE: Artificial Intelligence
Letters
C4IP Letter to FTC & DOJ RE: Drug Pricing Listening Sessions
Infographics & Fact Sheets
Drug Competition Enhancement Act Infographic
Infographics & Fact Sheets
Affordable Prescriptions for Patients Act Infographic
Public Comments
C4IP Comments RE: Foreign Nations Freeloading on American-Financed Innovation (USTR-2025-0011)
Public Comments
C4IP Comments RE: Draft Guidance on the Medicare Drug Price Negotiation Program
Issue Briefs
Drug Competition Enhancement Act
Issue Briefs
Affordable Prescriptions for Patients Act
Government AgendaReports
Reaffirm and Refine: A Government Agenda for Intellectual Property (Edition 2)

For the United States to maintain its competitive edge on the global stage, we must lead in innovation. This is only achievable...

Resources:

Resources:

C4IP Comments RE: U.K. IPO Consultation on SEPs,

10/03/2025

Resources:

Fact Checks, Resources:

Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Software and Technology,

09/25/2025

Resources:

Fact Checks, Resources:

Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Diagnostics and Life Sciences,

09/25/2025

Resources:

Resources:

C4IP Letter to House Judiciary Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet RE: Artificial Intelligence,

09/18/2025

Resources:

Resources:

C4IP Letter to FTC & DOJ RE: Drug Pricing Listening Sessions,

08/15/2025

Resources:

Resources:

Drug Competition Enhancement Act Infographic,

06/27/2025

Resources:

Resources:

Affordable Prescriptions for Patients Act Infographic,

06/27/2025

Resources:

Resources:

C4IP Comments RE: Foreign Nations Freeloading on American-Financed Innovation (USTR-2025-0011),

06/27/2025

Resources:

Resources:

C4IP Comments RE: Draft Guidance on the Medicare Drug Price Negotiation Program,

06/26/2025

Resources:

Resources:

Drug Competition Enhancement Act,

06/25/2025

Resources:

Resources:

Affordable Prescriptions for Patients Act,

06/24/2025

Resources:

Resources:

Reaffirm and Refine: A Government Agenda for Intellectual Property (Edition 2),

06/11/2025

Scroll to Top